Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2021-07-28 00:00:00 ET · period of report 2021-07-26 · accession 0001567619-21-014097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-07-28 | 2021-07-26+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $181.47 | -15.3K | 6.08M | -0.3% | -$2.78M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-26 | S | D | 15,209 | $181.47 | 6,075,530 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2021-07-27 | S | D | 131 | $180.93 | 6,075,399 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |